1. Quality of life evaluation of cpt-11 compared to best supportive care or infusional 5-fu in patients with 5-fu resistant advanced colorectal cancer;Blijham,1998
2. A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy. V301 Study Group;Cunningham;Semin Oncol,1999
3. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer;Cunningham;Lancet,1998
4. Phase III comparison of two Irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer;Fuchs;J Clin Oncol,,2003
5. A phase III, randomized, multicentre, trial of irinotecan until disease progression (PD) versus 8 cycles, in advanced colorectal cancer (CRC) resistant to fluoropyrimidines. 22;Lal;Proc Am Soc Clin Oncol,2003